These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1981879)

  • 21. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
    Hakamäki T; Lehtonen A
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of the effectiveness and tolerance of broxaterol in 10 patients with reversible bronchospasm].
    Scoditti S; Paladini A; Stomeo S; Toma P; Aversa C
    Arch Monaldi Mal Torace; 1987; 42(4):383-8. PubMed ID: 2908264
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
    Araújo DA; Farias ML; Andrade AT
    Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of galactose, glucose and fructose on carbohydrate-lipid metabolism.
    Manso JM; Jover E; Mayor F; Velasco R; Romero H
    J Med; 1979; 10(6):479-86. PubMed ID: 400743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Broxaterol: therapeutic trials and safety profile.
    Ziment I
    Respiration; 1989; 55 Suppl 2():28-40. PubMed ID: 2572038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Changes of circulation, blood gases, acid-base-and metabolism during neurolept-analgesia with and without beta-receptor blockers in electro coagulation of Gasser's ganglion (author's transl)].
    Knitza R; Olbermann M; Fischer F; Bässler KH
    Anaesthesist; 1978 May; 27(5):213-8. PubMed ID: 27127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of a beta 2-agonist (broxaterol) on respiratory muscle strength and endurance in patients with COPD with irreversible airway obstruction.
    Nava S; Crotti P; Gurrieri G; Fracchia C; Rampulla C
    Chest; 1992 Jan; 101(1):133-40. PubMed ID: 1345900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of beta 2-agonists during cardiopulmonary exercise test in COPD patients.
    Malerba M; Boni E; Romagnoni G; Filippi B; Politi A; Giustina A; Tantucci C; Grassi V
    Monaldi Arch Chest Dis; 1994 Dec; 49(5):389-93. PubMed ID: 7841973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gas exchange and arterial blood gas tensions to terbutaline sulfate in older patients with reversible airway obstruction.
    Ishikawa S; Linzmayer I; Segal MS
    Ann Allergy; 1977 Nov; 39(5):303-5. PubMed ID: 920996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Broxaterol: a double-blind clinical trial comparing broxaterol and salbutamol.
    Rampulla C; Corsico R; Majani U; Lodola E
    Respiration; 1985; 47(4):299-302. PubMed ID: 2861630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of broxaterol in bronchial hyperresponsiveness.
    Bianco S
    Respiration; 1989; 55 Suppl 2():20-7. PubMed ID: 2572037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacokinetics of broxaterol in asthmatic children].
    Flores D'Arcais A; Crippa L; De Biase D; Romagnoni G
    Minerva Pediatr; 1992 Sep; 44(9):421-5. PubMed ID: 1361960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thermogenic effect of the new beta-adrenoreceptor agonist Ro 16-8714 in healthy male volunteers.
    Henny C; Schutz Y; Buckert A; Meylan M; Jequier E; Felber JP
    Int J Obes; 1987; 11(5):473-83. PubMed ID: 2892807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a new beta-adrenoceptor agonist, procaterol, based on metabolic responses in rats.
    Saitoh Y; Irie Y; Hosokawa T; Igawa T; Hashimura F; Kohri H
    Biochem Pharmacol; 1978; 27(21):2531-5. PubMed ID: 31885
    [No Abstract]   [Full Text] [Related]  

  • 35. [Respiratory, cardiological and metabolic functional studies of the effects of salbutamol in bronchopathic patients of various ages].
    Babolini G; Gemelli M; Capone M; Coglitore G; Ministeri S; Girbino G; Pinizzotto G; Barberio G
    Minerva Med; 1976 Mar; 67(16):1058-66. PubMed ID: 1264381
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparative evaluation of the respiratory function and the acid-base equilibrium in patients with chronic bronchopulmonary disease after intravenous administration of 5 beta receptor agonists].
    Bianco S; Ferrara A; Bossi R; Moavero NE; Allegra L; Fumagalli G
    Minerva Med; 1979 Jan; 70(1):51-7. PubMed ID: 34813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Broxaterol: a new beta2-adrenoceptor agonist for the treatment of reversible airways disease. Proceedings of the satellite symposium. Budapest, September 8, 1988.
    Respiration; 1989; 55 Suppl 2():1-44. PubMed ID: 2572034
    [No Abstract]   [Full Text] [Related]  

  • 38. [Modification of the metabolism by NAB 365 and therapeutic effect in bronchial asthma].
    Becker VE; Nonhoff R
    Wien Med Wochenschr Suppl; 1975; 23():11-4. PubMed ID: 1094749
    [No Abstract]   [Full Text] [Related]  

  • 39. [Examination of cardiovascular parameters and plasma free fatty acids during esophago-gastro-duodenoscopy (author's transl)].
    Pristautz H; Biffl H; Pinl F
    Z Gastroenterol; 1978 Aug; 16(8):490-6. PubMed ID: 685345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic and cardiovascular effects of carbuterol and metaproterenol.
    Sanders JP; Potter DE; Ellis S; Bee DE; Grant JA
    J Allergy Clin Immunol; 1977 Sep; 60(3):174-9. PubMed ID: 19514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.